title: Saxagliptin and risk of heart failure hospitalization: Concern or miscalculation?
authors.affiliation: Centro de Salud San Antón, Cartagena, Spain.
authors.forename: Ana María
authors.initials: AM
authors.lastname: Cebrián-Cuenca
authors.affiliation: Centro de Salud Cabo Huertas, Alicante, Spain.
authors.forename: Domingo
authors.initials: D
authors.lastname: Orozco-Beltrán
authors.affiliation: Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain.
authors.forename: Jorge
authors.initials: J
authors.lastname: Navarro-Pérez
authors.affiliation: Centro de Salud Raval, Barcelona, Spain.
authors.forename: Josep
authors.initials: J
authors.lastname: Franch-Nadal
authors.affiliation: Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain.
authors.forename: Julio
authors.initials: J
authors.lastname: Núñez-Villota
authors.affiliation: Statistical Consulting Unit, Hospital Santa Lucia, Cartagena, Spain. Electronic address: lconsue@gmail.com.
authors.forename: Luciano
authors.initials: L
authors.lastname: Consuegra-Sánchez
mesh_terms: D000218:Adamantane / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004151:Dipeptides / Q000009:adverse effects / Q000627:therapeutic use*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006333:Heart Failure / Q000139:chemically induced* / Q000175:diagnosis*; D006760:Hospitalization / Q000639:trends*; D006801:Humans
chemical_list: D004151:Dipeptides; D054873:Dipeptidyl-Peptidase IV Inhibitors; C502994:saxagliptin; D000218:Adamantane
keywords: Heart failure; Multiplicity; Saxagliptin